ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Crawford Testimony in 2002 Promised Job to Pazdur.

February 18, 2005

Mendelsohn To Step Down As MD Anderson President

December 10, 2010

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

RFPs Go Out To Cooperative Groups for Community Programs

April 9, 1976

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002